The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cefotaxime Sodium API Market Insights and Forecast to 2028
Synopsis
Cefotaxime sodium is the sodium salt form of cefotaxime, a beta-lactam, third-generation cephalosporin antibiotic with bactericidal activity. Cefotaxime sodium binds to and inactivates penicillin-binding proteins (PBP) located on the inner membrane of the bacterial cell wall. Inactivation of PBPs interferes with the cross-linking of peptidoglycan chains necessary for bacterial cell wall strength and rigidity. This results in the weakening of the bacterial cell wall and causes cell lysis. Compared to the second and first generation cephalosporins, cefotaxime sodium is more active against gram-negative bacteria and less active against gram-positive bacteria.
Market Analysis and Insights: Global Cefotaxime Sodium API Market
Due to the COVID-19 pandemic, the global Cefotaxime Sodium API market size is estimated to be worth US$ 100.3 million in 2022 and is forecast to a readjusted size of US$ 96 million by 2028 with a CAGR of -0.8% during the review period. Fully considering the economic change by this health crisis, ChP accounting for % of the Cefotaxime Sodium API global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Single Injection segment is altered to an % CAGR throughout this forecast period.
Market competition is intense. REYOUNG, Nectar Lifesciences, Medya Pharma, Sandoz, Kelun, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. Top 5 manufacturers accountted for 57.98% market share in 2019.
Global Cefotaxime Sodium API Scope and Segment
Cefotaxime Sodium API market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Cefotaxime Sodium API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
ChP
USP
EP
Segment by Application
Single Injection
Compound Injection
By Company
REYOUNG
Nectar Lifesciences
Medya Pharma
Sandoz
Kelun
NCPC
Aurobindo Pharma
United Laboratories
Orchid Pharma
CSPC
Kopran
Covalent
ACS Dobfar
Dawnrays
Sterile India
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Cefotaxime sodium is the sodium salt form of cefotaxime, a beta-lactam, third-generation cephalosporin antibiotic with bactericidal activity. Cefotaxime sodium binds to and inactivates penicillin-binding proteins (PBP) located on the inner membrane of the bacterial cell wall. Inactivation of PBPs interferes with the cross-linking of peptidoglycan chains necessary for bacterial cell wall strength and rigidity. This results in the weakening of the bacterial cell wall and causes cell lysis. Compared to the second and first generation cephalosporins, cefotaxime sodium is more active against gram-negative bacteria and less active against gram-positive bacteria.
Market Analysis and Insights: Global Cefotaxime Sodium API Market
Due to the COVID-19 pandemic, the global Cefotaxime Sodium API market size is estimated to be worth US$ 100.3 million in 2022 and is forecast to a readjusted size of US$ 96 million by 2028 with a CAGR of -0.8% during the review period. Fully considering the economic change by this health crisis, ChP accounting for % of the Cefotaxime Sodium API global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Single Injection segment is altered to an % CAGR throughout this forecast period.
Market competition is intense. REYOUNG, Nectar Lifesciences, Medya Pharma, Sandoz, Kelun, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. Top 5 manufacturers accountted for 57.98% market share in 2019.
Global Cefotaxime Sodium API Scope and Segment
Cefotaxime Sodium API market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Cefotaxime Sodium API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
ChP
USP
EP
Segment by Application
Single Injection
Compound Injection
By Company
REYOUNG
Nectar Lifesciences
Medya Pharma
Sandoz
Kelun
NCPC
Aurobindo Pharma
United Laboratories
Orchid Pharma
CSPC
Kopran
Covalent
ACS Dobfar
Dawnrays
Sterile India
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Index1 Study Coverage
1.1 Cefotaxime Sodium API Product Introduction
1.2 Market by Type
1.2.1 Global Cefotaxime Sodium API Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 ChP
1.2.3 USP
1.2.4 EP
1.3 Market by Application
1.3.1 Global Cefotaxime Sodium API Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Single Injection
1.3.3 Compound Injection
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Cefotaxime Sodium API Sales Estimates and Forecasts 2017-2028
2.2 Global Cefotaxime Sodium API Revenue Estimates and Forecasts 2017-2028
2.3 Global Cefotaxime Sodium API Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Cefotaxime Sodium API Sales by Region
2.4.1 Global Cefotaxime Sodium API Sales by Region (2017-2022)
2.4.2 Global Sales Cefotaxime Sodium API by Region (2023-2028)
2.5 Global Cefotaxime Sodium API Revenue by Region
2.5.1 Global Cefotaxime Sodium API Revenue by Region (2017-2022)
2.5.2 Global Cefotaxime Sodium API Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Cefotaxime Sodium API Sales by Manufacturers
3.1.1 Global Top Cefotaxime Sodium API Manufacturers by Sales (2017-2022)
3.1.2 Global Cefotaxime Sodium API Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Cefotaxime Sodium API in 2021
3.2 Global Cefotaxime Sodium API Revenue by Manufacturers
3.2.1 Global Cefotaxime Sodium API Revenue by Manufacturers (2017-2022)
3.2.2 Global Cefotaxime Sodium API Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Cefotaxime Sodium API Revenue in 2021
3.3 Global Cefotaxime Sodium API Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Cefotaxime Sodium API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Cefotaxime Sodium API Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Cefotaxime Sodium API Sales by Type
4.1.1 Global Cefotaxime Sodium API Historical Sales by Type (2017-2022)
4.1.2 Global Cefotaxime Sodium API Forecasted Sales by Type (2023-2028)
4.1.3 Global Cefotaxime Sodium API Sales Market Share by Type (2017-2028)
4.2 Global Cefotaxime Sodium API Revenue by Type
4.2.1 Global Cefotaxime Sodium API Historical Revenue by Type (2017-2022)
4.2.2 Global Cefotaxime Sodium API Forecasted Revenue by Type (2023-2028)
4.2.3 Global Cefotaxime Sodium API Revenue Market Share by Type (2017-2028)
4.3 Global Cefotaxime Sodium API Price by Type
4.3.1 Global Cefotaxime Sodium API Price by Type (2017-2022)
4.3.2 Global Cefotaxime Sodium API Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Cefotaxime Sodium API Sales by Application
5.1.1 Global Cefotaxime Sodium API Historical Sales by Application (2017-2022)
5.1.2 Global Cefotaxime Sodium API Forecasted Sales by Application (2023-2028)
5.1.3 Global Cefotaxime Sodium API Sales Market Share by Application (2017-2028)
5.2 Global Cefotaxime Sodium API Revenue by Application
5.2.1 Global Cefotaxime Sodium API Historical Revenue by Application (2017-2022)
5.2.2 Global Cefotaxime Sodium API Forecasted Revenue by Application (2023-2028)
5.2.3 Global Cefotaxime Sodium API Revenue Market Share by Application (2017-2028)
5.3 Global Cefotaxime Sodium API Price by Application
5.3.1 Global Cefotaxime Sodium API Price by Application (2017-2022)
5.3.2 Global Cefotaxime Sodium API Price Forecast by Application (2023-2028)
6 North America
6.1 North America Cefotaxime Sodium API Market Size by Type
6.1.1 North America Cefotaxime Sodium API Sales by Type (2017-2028)
6.1.2 North America Cefotaxime Sodium API Revenue by Type (2017-2028)
6.2 North America Cefotaxime Sodium API Market Size by Application
6.2.1 North America Cefotaxime Sodium API Sales by Application (2017-2028)
6.2.2 North America Cefotaxime Sodium API Revenue by Application (2017-2028)
6.3 North America Cefotaxime Sodium API Market Size by Country
6.3.1 North America Cefotaxime Sodium API Sales by Country (2017-2028)
6.3.2 North America Cefotaxime Sodium API Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Cefotaxime Sodium API Market Size by Type
7.1.1 Europe Cefotaxime Sodium API Sales by Type (2017-2028)
7.1.2 Europe Cefotaxime Sodium API Revenue by Type (2017-2028)
7.2 Europe Cefotaxime Sodium API Market Size by Application
7.2.1 Europe Cefotaxime Sodium API Sales by Application (2017-2028)
7.2.2 Europe Cefotaxime Sodium API Revenue by Application (2017-2028)
7.3 Europe Cefotaxime Sodium API Market Size by Country
7.3.1 Europe Cefotaxime Sodium API Sales by Country (2017-2028)
7.3.2 Europe Cefotaxime Sodium API Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Cefotaxime Sodium API Market Size by Type
8.1.1 Asia Pacific Cefotaxime Sodium API Sales by Type (2017-2028)
8.1.2 Asia Pacific Cefotaxime Sodium API Revenue by Type (2017-2028)
8.2 Asia Pacific Cefotaxime Sodium API Market Size by Application
8.2.1 Asia Pacific Cefotaxime Sodium API Sales by Application (2017-2028)
8.2.2 Asia Pacific Cefotaxime Sodium API Revenue by Application (2017-2028)
8.3 Asia Pacific Cefotaxime Sodium API Market Size by Region
8.3.1 Asia Pacific Cefotaxime Sodium API Sales by Region (2017-2028)
8.3.2 Asia Pacific Cefotaxime Sodium API Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Cefotaxime Sodium API Market Size by Type
9.1.1 Latin America Cefotaxime Sodium API Sales by Type (2017-2028)
9.1.2 Latin America Cefotaxime Sodium API Revenue by Type (2017-2028)
9.2 Latin America Cefotaxime Sodium API Market Size by Application
9.2.1 Latin America Cefotaxime Sodium API Sales by Application (2017-2028)
9.2.2 Latin America Cefotaxime Sodium API Revenue by Application (2017-2028)
9.3 Latin America Cefotaxime Sodium API Market Size by Country
9.3.1 Latin America Cefotaxime Sodium API Sales by Country (2017-2028)
9.3.2 Latin America Cefotaxime Sodium API Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Cefotaxime Sodium API Market Size by Type
10.1.1 Middle East and Africa Cefotaxime Sodium API Sales by Type (2017-2028)
10.1.2 Middle East and Africa Cefotaxime Sodium API Revenue by Type (2017-2028)
10.2 Middle East and Africa Cefotaxime Sodium API Market Size by Application
10.2.1 Middle East and Africa Cefotaxime Sodium API Sales by Application (2017-2028)
10.2.2 Middle East and Africa Cefotaxime Sodium API Revenue by Application (2017-2028)
10.3 Middle East and Africa Cefotaxime Sodium API Market Size by Country
10.3.1 Middle East and Africa Cefotaxime Sodium API Sales by Country (2017-2028)
10.3.2 Middle East and Africa Cefotaxime Sodium API Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 REYOUNG
11.1.1 REYOUNG Corporation Information
11.1.2 REYOUNG Overview
11.1.3 REYOUNG Cefotaxime Sodium API Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 REYOUNG Cefotaxime Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 REYOUNG Recent Developments
11.2 Nectar Lifesciences
11.2.1 Nectar Lifesciences Corporation Information
11.2.2 Nectar Lifesciences Overview
11.2.3 Nectar Lifesciences Cefotaxime Sodium API Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Nectar Lifesciences Cefotaxime Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Nectar Lifesciences Recent Developments
11.3 Medya Pharma
11.3.1 Medya Pharma Corporation Information
11.3.2 Medya Pharma Overview
11.3.3 Medya Pharma Cefotaxime Sodium API Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Medya Pharma Cefotaxime Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Medya Pharma Recent Developments
11.4 Sandoz
11.4.1 Sandoz Corporation Information
11.4.2 Sandoz Overview
11.4.3 Sandoz Cefotaxime Sodium API Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Sandoz Cefotaxime Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sandoz Recent Developments
11.5 Kelun
11.5.1 Kelun Corporation Information
11.5.2 Kelun Overview
11.5.3 Kelun Cefotaxime Sodium API Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Kelun Cefotaxime Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Kelun Recent Developments
11.6 NCPC
11.6.1 NCPC Corporation Information
11.6.2 NCPC Overview
11.6.3 NCPC Cefotaxime Sodium API Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 NCPC Cefotaxime Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 NCPC Recent Developments
11.7 Aurobindo Pharma
11.7.1 Aurobindo Pharma Corporation Information
11.7.2 Aurobindo Pharma Overview
11.7.3 Aurobindo Pharma Cefotaxime Sodium API Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Aurobindo Pharma Cefotaxime Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Aurobindo Pharma Recent Developments
11.8 United Laboratories
11.8.1 United Laboratories Corporation Information
11.8.2 United Laboratories Overview
11.8.3 United Laboratories Cefotaxime Sodium API Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 United Laboratories Cefotaxime Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 United Laboratories Recent Developments
11.9 Orchid Pharma
11.9.1 Orchid Pharma Corporation Information
11.9.2 Orchid Pharma Overview
11.9.3 Orchid Pharma Cefotaxime Sodium API Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Orchid Pharma Cefotaxime Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Orchid Pharma Recent Developments
11.10 CSPC
11.10.1 CSPC Corporation Information
11.10.2 CSPC Overview
11.10.3 CSPC Cefotaxime Sodium API Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 CSPC Cefotaxime Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 CSPC Recent Developments
11.11 Kopran
11.11.1 Kopran Corporation Information
11.11.2 Kopran Overview
11.11.3 Kopran Cefotaxime Sodium API Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Kopran Cefotaxime Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Kopran Recent Developments
11.12 Covalent
11.12.1 Covalent Corporation Information
11.12.2 Covalent Overview
11.12.3 Covalent Cefotaxime Sodium API Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Covalent Cefotaxime Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Covalent Recent Developments
11.13 ACS Dobfar
11.13.1 ACS Dobfar Corporation Information
11.13.2 ACS Dobfar Overview
11.13.3 ACS Dobfar Cefotaxime Sodium API Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 ACS Dobfar Cefotaxime Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 ACS Dobfar Recent Developments
11.14 Dawnrays
11.14.1 Dawnrays Corporation Information
11.14.2 Dawnrays Overview
11.14.3 Dawnrays Cefotaxime Sodium API Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Dawnrays Cefotaxime Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Dawnrays Recent Developments
11.15 Sterile India
11.15.1 Sterile India Corporation Information
11.15.2 Sterile India Overview
11.15.3 Sterile India Cefotaxime Sodium API Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Sterile India Cefotaxime Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Sterile India Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Cefotaxime Sodium API Industry Chain Analysis
12.2 Cefotaxime Sodium API Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Cefotaxime Sodium API Production Mode & Process
12.4 Cefotaxime Sodium API Sales and Marketing
12.4.1 Cefotaxime Sodium API Sales Channels
12.4.2 Cefotaxime Sodium API Distributors
12.5 Cefotaxime Sodium API Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Cefotaxime Sodium API Industry Trends
13.2 Cefotaxime Sodium API Market Drivers
13.3 Cefotaxime Sodium API Market Challenges
13.4 Cefotaxime Sodium API Market Restraints
14 Key Findings in The Global Cefotaxime Sodium API Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of TablesList of Tables
Table 1. Global Cefotaxime Sodium API Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of ChP
Table 3. Major Manufacturers of USP
Table 4. Major Manufacturers of EP
Table 5. Global Cefotaxime Sodium API Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Cefotaxime Sodium API Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Cefotaxime Sodium API Sales by Region (2017-2022) & (MT)
Table 8. Global Cefotaxime Sodium API Sales Market Share by Region (2017-2022)
Table 9. Global Cefotaxime Sodium API Sales by Region (2023-2028) & (MT)
Table 10. Global Cefotaxime Sodium API Sales Market Share by Region (2023-2028)
Table 11. Global Cefotaxime Sodium API Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Cefotaxime Sodium API Revenue Market Share by Region (2017-2022)
Table 13. Global Cefotaxime Sodium API Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Cefotaxime Sodium API Revenue Market Share by Region (2023-2028)
Table 15. Global Cefotaxime Sodium API Sales by Manufacturers (2017-2022) & (MT)
Table 16. Global Cefotaxime Sodium API Sales Share by Manufacturers (2017-2022)
Table 17. Global Cefotaxime Sodium API Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Cefotaxime Sodium API Revenue Share by Manufacturers (2017-2022)
Table 19. Cefotaxime Sodium API Price by Manufacturers (2017-2022) &(USD/MT)
Table 20. Global Cefotaxime Sodium API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Cefotaxime Sodium API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cefotaxime Sodium API as of 2021)
Table 22. Cefotaxime Sodium API Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Cefotaxime Sodium API Product Offered
Table 24. Date of Manufacturers Enter into Cefotaxime Sodium API Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cefotaxime Sodium API Sales by Type (2017-2022) & (MT)
Table 27. Global Cefotaxime Sodium API Sales by Type (2023-2028) & (MT)
Table 28. Global Cefotaxime Sodium API Sales Share by Type (2017-2022)
Table 29. Global Cefotaxime Sodium API Sales Share by Type (2023-2028)
Table 30. Global Cefotaxime Sodium API Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Cefotaxime Sodium API Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Cefotaxime Sodium API Revenue Share by Type (2017-2022)
Table 33. Global Cefotaxime Sodium API Revenue Share by Type (2023-2028)
Table 34. Cefotaxime Sodium API Price by Type (2017-2022) & (USD/MT)
Table 35. Global Cefotaxime Sodium API Price Forecast by Type (2023-2028) & (USD/MT)
Table 36. Global Cefotaxime Sodium API Sales by Application (2017-2022) & (MT)
Table 37. Global Cefotaxime Sodium API Sales by Application (2023-2028) & (MT)
Table 38. Global Cefotaxime Sodium API Sales Share by Application (2017-2022)
Table 39. Global Cefotaxime Sodium API Sales Share by Application (2023-2028)
Table 40. Global Cefotaxime Sodium API Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Cefotaxime Sodium API Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Cefotaxime Sodium API Revenue Share by Application (2017-2022)
Table 43. Global Cefotaxime Sodium API Revenue Share by Application (2023-2028)
Table 44. Cefotaxime Sodium API Price by Application (2017-2022) & (USD/MT)
Table 45. Global Cefotaxime Sodium API Price Forecast by Application (2023-2028) & (USD/MT)
Table 46. North America Cefotaxime Sodium API Sales by Type (2017-2022) & (MT)
Table 47. North America Cefotaxime Sodium API Sales by Type (2023-2028) & (MT)
Table 48. North America Cefotaxime Sodium API Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Cefotaxime Sodium API Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Cefotaxime Sodium API Sales by Application (2017-2022) & (MT)
Table 51. North America Cefotaxime Sodium API Sales by Application (2023-2028) & (MT)
Table 52. North America Cefotaxime Sodium API Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Cefotaxime Sodium API Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Cefotaxime Sodium API Sales by Country (2017-2022) & (MT)
Table 55. North America Cefotaxime Sodium API Sales by Country (2023-2028) & (MT)
Table 56. North America Cefotaxime Sodium API Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Cefotaxime Sodium API Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Cefotaxime Sodium API Sales by Type (2017-2022) & (MT)
Table 59. Europe Cefotaxime Sodium API Sales by Type (2023-2028) & (MT)
Table 60. Europe Cefotaxime Sodium API Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Cefotaxime Sodium API Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Cefotaxime Sodium API Sales by Application (2017-2022) & (MT)
Table 63. Europe Cefotaxime Sodium API Sales by Application (2023-2028) & (MT)
Table 64. Europe Cefotaxime Sodium API Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Cefotaxime Sodium API Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Cefotaxime Sodium API Sales by Country (2017-2022) & (MT)
Table 67. Europe Cefotaxime Sodium API Sales by Country (2023-2028) & (MT)
Table 68. Europe Cefotaxime Sodium API Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Cefotaxime Sodium API Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Cefotaxime Sodium API Sales by Type (2017-2022) & (MT)
Table 71. Asia Pacific Cefotaxime Sodium API Sales by Type (2023-2028) & (MT)
Table 72. Asia Pacific Cefotaxime Sodium API Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Cefotaxime Sodium API Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Cefotaxime Sodium API Sales by Application (2017-2022) & (MT)
Table 75. Asia Pacific Cefotaxime Sodium API Sales by Application (2023-2028) & (MT)
Table 76. Asia Pacific Cefotaxime Sodium API Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Cefotaxime Sodium API Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Cefotaxime Sodium API Sales by Region (2017-2022) & (MT)
Table 79. Asia Pacific Cefotaxime Sodium API Sales by Region (2023-2028) & (MT)
Table 80. Asia Pacific Cefotaxime Sodium API Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Cefotaxime Sodium API Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Cefotaxime Sodium API Sales by Type (2017-2022) & (MT)
Table 83. Latin America Cefotaxime Sodium API Sales by Type (2023-2028) & (MT)
Table 84. Latin America Cefotaxime Sodium API Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Cefotaxime Sodium API Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Cefotaxime Sodium API Sales by Application (2017-2022) & (MT)
Table 87. Latin America Cefotaxime Sodium API Sales by Application (2023-2028) & (MT)
Table 88. Latin America Cefotaxime Sodium API Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Cefotaxime Sodium API Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Cefotaxime Sodium API Sales by Country (2017-2022) & (MT)
Table 91. Latin America Cefotaxime Sodium API Sales by Country (2023-2028) & (MT)
Table 92. Latin America Cefotaxime Sodium API Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Cefotaxime Sodium API Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Cefotaxime Sodium API Sales by Type (2017-2022) & (MT)
Table 95. Middle East and Africa Cefotaxime Sodium API Sales by Type (2023-2028) & (MT)
Table 96. Middle East and Africa Cefotaxime Sodium API Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Cefotaxime Sodium API Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Cefotaxime Sodium API Sales by Application (2017-2022) & (MT)
Table 99. Middle East and Africa Cefotaxime Sodium API Sales by Application (2023-2028) & (MT)
Table 100. Middle East and Africa Cefotaxime Sodium API Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Cefotaxime Sodium API Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Cefotaxime Sodium API Sales by Country (2017-2022) & (MT)
Table 103. Middle East and Africa Cefotaxime Sodium API Sales by Country (2023-2028) & (MT)
Table 104. Middle East and Africa Cefotaxime Sodium API Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Cefotaxime Sodium API Revenue by Country (2023-2028) & (US$ Million)
Table 106. REYOUNG Corporation Information
Table 107. REYOUNG Description and Major Businesses
Table 108. REYOUNG Cefotaxime Sodium API Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 109. REYOUNG Cefotaxime Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. REYOUNG Recent Developments
Table 111. Nectar Lifesciences Corporation Information
Table 112. Nectar Lifesciences Description and Major Businesses
Table 113. Nectar Lifesciences Cefotaxime Sodium API Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 114. Nectar Lifesciences Cefotaxime Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Nectar Lifesciences Recent Developments
Table 116. Medya Pharma Corporation Information
Table 117. Medya Pharma Description and Major Businesses
Table 118. Medya Pharma Cefotaxime Sodium API Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 119. Medya Pharma Cefotaxime Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Medya Pharma Recent Developments
Table 121. Sandoz Corporation Information
Table 122. Sandoz Description and Major Businesses
Table 123. Sandoz Cefotaxime Sodium API Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 124. Sandoz Cefotaxime Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Sandoz Recent Developments
Table 126. Kelun Corporation Information
Table 127. Kelun Description and Major Businesses
Table 128. Kelun Cefotaxime Sodium API Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 129. Kelun Cefotaxime Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Kelun Recent Developments
Table 131. NCPC Corporation Information
Table 132. NCPC Description and Major Businesses
Table 133. NCPC Cefotaxime Sodium API Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 134. NCPC Cefotaxime Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. NCPC Recent Developments
Table 136. Aurobindo Pharma Corporation Information
Table 137. Aurobindo Pharma Description and Major Businesses
Table 138. Aurobindo Pharma Cefotaxime Sodium API Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 139. Aurobindo Pharma Cefotaxime Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Aurobindo Pharma Recent Developments
Table 141. United Laboratories Corporation Information
Table 142. United Laboratories Description and Major Businesses
Table 143. United Laboratories Cefotaxime Sodium API Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 144. United Laboratories Cefotaxime Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. United Laboratories Recent Developments
Table 146. Orchid Pharma Corporation Information
Table 147. Orchid Pharma Description and Major Businesses
Table 148. Orchid Pharma Cefotaxime Sodium API Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 149. Orchid Pharma Cefotaxime Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Orchid Pharma Recent Developments
Table 151. CSPC Corporation Information
Table 152. CSPC Description and Major Businesses
Table 153. CSPC Cefotaxime Sodium API Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 154. CSPC Cefotaxime Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. CSPC Recent Developments
Table 156. Kopran Corporation Information
Table 157. Kopran Description and Major Businesses
Table 158. Kopran Cefotaxime Sodium API Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 159. Kopran Cefotaxime Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
Table 160. Kopran Recent Developments
Table 161. Covalent Corporation Information
Table 162. Covalent Description and Major Businesses
Table 163. Covalent Cefotaxime Sodium API Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 164. Covalent Cefotaxime Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
Table 165. Covalent Recent Developments
Table 166. ACS Dobfar Corporation Information
Table 167. ACS Dobfar Description and Major Businesses
Table 168. ACS Dobfar Cefotaxime Sodium API Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 169. ACS Dobfar Cefotaxime Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
Table 170. ACS Dobfar Recent Developments
Table 171. Dawnrays Corporation Information
Table 172. Dawnrays Description and Major Businesses
Table 173. Dawnrays Cefotaxime Sodium API Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 174. Dawnrays Cefotaxime Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
Table 175. Dawnrays Recent Developments
Table 176. Sterile India Corporation Information
Table 177. Sterile India Description and Major Businesses
Table 178. Sterile India Cefotaxime Sodium API Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 179. Sterile India Cefotaxime Sodium API Product Model Numbers, Pictures, Descriptions and Specifications
Table 180. Sterile India Recent Developments
Table 181. Key Raw Materials Lists
Table 182. Raw Materials Key Suppliers Lists
Table 183. Cefotaxime Sodium API Distributors List
Table 184. Cefotaxime Sodium API Customers List
Table 185. Cefotaxime Sodium API Market Trends
Table 186. Cefotaxime Sodium API Market Drivers
Table 187. Cefotaxime Sodium API Market Challenges
Table 188. Cefotaxime Sodium API Market Restraints
Table 189. Research Programs/Design for This Report
Table 190. Key Data Information from Secondary Sources
Table 191. Key Data Information from Primary Sources
List of Figures
Figure 1. Cefotaxime Sodium API Product Picture
Figure 3. Global Cefotaxime Sodium API Market Share by Type in 2021 & 2028
Figure 3. ChP Product Picture
Figure 4. USP Product Picture
Figure 5. EP Product Picture
Figure 6. Global Cefotaxime Sodium API Market Share by Application in 2021 & 2028
Figure 7. Single Injection
Figure 8. Compound Injection
Figure 9. Cefotaxime Sodium API Report Years Considered
Figure 10. Global Cefotaxime Sodium API Sales 2017-2028 (MT)
Figure 11. Global Cefotaxime Sodium API Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Cefotaxime Sodium API Revenue 2017-2028 (US$ Million)
Figure 13. Global Cefotaxime Sodium API Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Cefotaxime Sodium API Sales Market Share by Region (2017-2022)
Figure 15. Global Cefotaxime Sodium API Sales Market Share by Region (2023-2028)
Figure 16. North America Cefotaxime Sodium API Sales YoY (2017-2028) & (MT)
Figure 17. North America Cefotaxime Sodium API Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Cefotaxime Sodium API Sales YoY (2017-2028) & (MT)
Figure 19. Europe Cefotaxime Sodium API Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Cefotaxime Sodium API Sales YoY (2017-2028) & (MT)
Figure 21. Asia-Pacific Cefotaxime Sodium API Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Cefotaxime Sodium API Sales YoY (2017-2028) & (MT)
Figure 23. Latin America Cefotaxime Sodium API Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Cefotaxime Sodium API Sales YoY (2017-2028) & (MT)
Figure 25. Middle East & Africa Cefotaxime Sodium API Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Cefotaxime Sodium API Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Cefotaxime Sodium API in the World: Market Share by Cefotaxime Sodium API Revenue in 2021
Figure 28. Global Cefotaxime Sodium API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Cefotaxime Sodium API Sales Market Share by Type (2017-2028)
Figure 30. Global Cefotaxime Sodium API Revenue Market Share by Type (2017-2028)
Figure 31. Global Cefotaxime Sodium API Sales Market Share by Application (2017-2028)
Figure 32. Global Cefotaxime Sodium API Revenue Market Share by Application (2017-2028)
Figure 33. North America Cefotaxime Sodium API Sales Market Share by Type (2017-2028)
Figure 34. North America Cefotaxime Sodium API Revenue Market Share by Type (2017-2028)
Figure 35. North America Cefotaxime Sodium API Sales Market Share by Application (2017-2028)
Figure 36. North America Cefotaxime Sodium API Revenue Market Share by Application (2017-2028)
Figure 37. North America Cefotaxime Sodium API Sales Share by Country (2017-2028)
Figure 38. North America Cefotaxime Sodium API Revenue Share by Country (2017-2028)
Figure 39. U.S. Cefotaxime Sodium API Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Cefotaxime Sodium API Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Cefotaxime Sodium API Sales Market Share by Type (2017-2028)
Figure 42. Europe Cefotaxime Sodium API Revenue Market Share by Type (2017-2028)
Figure 43. Europe Cefotaxime Sodium API Sales Market Share by Application (2017-2028)
Figure 44. Europe Cefotaxime Sodium API Revenue Market Share by Application (2017-2028)
Figure 45. Europe Cefotaxime Sodium API Sales Share by Country (2017-2028)
Figure 46. Europe Cefotaxime Sodium API Revenue Share by Country (2017-2028)
Figure 47. Germany Cefotaxime Sodium API Revenue (2017-2028) & (US$ Million)
Figure 48. France Cefotaxime Sodium API Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Cefotaxime Sodium API Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Cefotaxime Sodium API Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Cefotaxime Sodium API Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Cefotaxime Sodium API Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Cefotaxime Sodium API Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Cefotaxime Sodium API Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Cefotaxime Sodium API Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Cefotaxime Sodium API Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Cefotaxime Sodium API Revenue Share by Region (2017-2028)
Figure 58. China Cefotaxime Sodium API Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Cefotaxime Sodium API Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Cefotaxime Sodium API Revenue (2017-2028) & (US$ Million)
Figure 61. India Cefotaxime Sodium API Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Cefotaxime Sodium API Revenue (2017-2028) & (US$ Million)
Figure 63. Taiwan Cefotaxime Sodium API Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Cefotaxime Sodium API Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Cefotaxime Sodium API Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Cefotaxime Sodium API Revenue (2017-2028) & (US$ Million)
Figure 67. Philippines Cefotaxime Sodium API Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Cefotaxime Sodium API Sales Market Share by Type (2017-2028)
Figure 69. Latin America Cefotaxime Sodium API Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Cefotaxime Sodium API Sales Market Share by Application (2017-2028)
Figure 71. Latin America Cefotaxime Sodium API Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Cefotaxime Sodium API Sales Share by Country (2017-2028)
Figure 73. Latin America Cefotaxime Sodium API Revenue Share by Country (2017-2028)
Figure 74. Mexico Cefotaxime Sodium API Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Cefotaxime Sodium API Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Cefotaxime Sodium API Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Cefotaxime Sodium API Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Cefotaxime Sodium API Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Cefotaxime Sodium API Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Cefotaxime Sodium API Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Cefotaxime Sodium API Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Cefotaxime Sodium API Revenue Share by Country (2017-2028)
Figure 83. Turkey Cefotaxime Sodium API Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Cefotaxime Sodium API Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Cefotaxime Sodium API Revenue (2017-2028) & (US$ Million)
Figure 86. Cefotaxime Sodium API Value Chain
Figure 87. Cefotaxime Sodium API Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
